POTTER MYRTLE S

SEC Form 4 insider trading activity

POTTER MYRTLE S has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jun 23, 2026.

On the most recent filing, POTTER MYRTLE S is listed as Director at Guardant Health, Inc. Inside the rolling window, POTTER MYRTLE S reported no open-market purchases and 1 open-market sale totaling $204K in GH.

Companies traded

Other insiders at GH

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$204K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
GH
POTTER MYRTLE S
Sale$204KJun 23SEC ↗
Showing 1–1 of 1
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Oct 17, 2025GHSale$2K
Sep 17, 2025GHSale$1K
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has POTTER MYRTLE S made?

POTTER MYRTLE S has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.

Which companies does POTTER MYRTLE S trade?

POTTER MYRTLE S has filed SEC Form 4 disclosures for 1 company, including GH.

When was POTTER MYRTLE S's most recent SEC Form 4 filing?

POTTER MYRTLE S's most recent SEC Form 4 filing on Tracefour is dated Jun 23, 2026.

What is POTTER MYRTLE S's total buy and sell value in the current window?

Inside the rolling retention window, POTTER MYRTLE S bought $0 and sold $204K based on SEC Form 4 filings.

What was POTTER MYRTLE S's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 1,556 GH shares on 2026-06-22, worth $204K, per SEC Form 4 filings.